Isoptin Dc

Verapamil Hydrochloride, the active ingredient in Isoptin Dc, is a calcium channel blocker presented as an oral tablet for systemic use. It is employed to lower high blood pressure, relieve chest pain caused by angina pectoris, and control certain supraventricular cardiac arrhythmias in adult patients.

GNH USA supplies Isoptin Dc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet European Union regulatory standards and are shipped with appropriate documentation for global distribution.

Verapamil is a calcium channel blocker used to manage cardiovascular conditions.

- Hypertension: lowers systemic blood pressure by causing peripheral vasodilation. - Angina pectoris: reduces frequency and severity of chest pain by improving myocardial oxygen balance. - Cardiac arrhythmias (e.g., supraventricular tachycardia): controls abnormal heart rhythms by slowing atrioventricular nodal conduction.

Verapamil may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate discomfort often occurring early in therapy. - Constipation: reduced bowel motility leading to infrequent, hard stools. - Dizziness or light‑headedness: due to transient blood pressure lowering. - Peripheral edema: swelling of ankles or feet from vasodilatory effects. - Flushing: warm sensation and reddening of skin. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate requiring medical evaluation. - Heart block: impaired electrical conduction that may necessitate pacing. - Severe hypotension: abrupt drop in blood pressure causing fainting. - Acute myocardial infarction: rare worsening of chest pain. - Hepatotoxicity: abnormal liver function tests. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy, clinicians should assess patient-specific risk factors and monitor for potential complications.

- Cardiac function: evaluate for existing heart block or severe left ventricular dysfunction. - Concomitant medications: review drugs that affect heart rate or blood pressure. - Liver impairment: adjust use in patients with hepatic disease. - Renal impairment: consider dose modification in severe renal dysfunction. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Verapamil interacts with several drug classes; careful assessment is required to avoid adverse outcomes.

Major Interactions (Avoid): - Beta‑blockers: combined use may cause profound bradycardia or heart block. - Digoxin: increased serum levels leading to toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise verapamil concentrations. - Certain anti‑arrhythmics (e.g., quinidine, amiodarone): risk of excessive conduction delay.

Moderate Interactions (Monitor Closely): - Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): monitor for muscle toxicity. - Antihypertensives (e.g., ACE inhibitors, diuretics): watch for additive blood pressure lowering. - Antacids containing aluminum or magnesium: may reduce absorption; separate administration by at least 2 hours.